Advertisement

November 6, 2020

Vascular Barcelona’s Varixio and CrabClamp Platforms Gain CE Mark Approval

November 6, 2020—Vascular Barcelona Devices, SL (VB Devices) announced European CE Mark approval for its Varixio Pod Air product, which automates the preparation of foam for sclerotherapy of varicose veins. The Varixio device consistently yields high-quality, standardized foam, for any sclerosant type and concentration, which will allow the use of foam sclerotherapy as a treatment option to varicose veins of all sizes, stated VB Devices.

Vascular surgeon Enric Roche, MD, who is cofounder of VB Devices, commented in the company’s announcement, “I am very pleased to see this device reach the market and excited about the opportunity it represents to expand sclerotherapy and successfully bring this minimally invasive procedure to even more patients.”

On October 31, VB Devices received CE Mark approval for its CrabClamp device, which allows surgeons and their assistants to easily secure guidewires and catheters during endovascular procedures. The device facilitates procedures by avoiding the risk of guidewire loss or untimely movement while contributing to keeping an orderly surgical field.

VB Devices noted that the CrabClamp is particularly useful in procedures in which surgeons have limited assistance or those that may be particularly complex such as endovascular aneurysm repair procedures. These procedures use two femoral accesses where it is essential to keep one of the guidewires stable while working with the other access.

The company will launch the CrabClamp in Europe in January 2021 while continuing to expand its global distribution network.

Advertisement


November 6, 2020

5-Year Data From IN.PACT Global Study Show Sustained Safety and Efficacy for Medtronic’s In.Pact Admiral DCB

November 6, 2020

SUNSET sPE Trial Compares Standard Versus Ultrasound-Assisted Thrombolysis to Treat Submassive Pulmonary Embolism